UnitedHealth's stock has dropped over 10% in three months due to shrinking membership, particularly in Medicare Advantage. Despite this, Morgan Stanley raised its price target to $529, forecasting a 40% upside based on expected margin improvements, growth in its Optum business, and an aging population driving Medicare Advantage enrollment. The company beat Q3 earnings estimates and raised full-year guidance, but faces risks from legal actions and membership declines. Investors should watch upcoming membership updates to gauge future performance.
UnitedHealth's stock is trading at USD 388.34 on Pluang, up 2.80% in the past day, despite the recent three-month decline noted in the article. Morgan Stanley shares are down 3.33% at USD 180.45, while Elevance Health is slightly down 0.71% at USD 422.24. These figures reflect active trading and investor interest as of Oct 15, 2026 00:02 WIB.
UnitedHealth Group reported strong Q3 2026 results, with adjusted earnings per share of $4.69, surpassing estimates of $4.14. Revenue also exceeded expectations at $112.70 billion. The company raised its full-year outlook, reflecting solid operationa...
UnitedHealth Group reported better-than-expected Q3 2026 results, beating both revenue and earnings estimates. The company raised its full-year guidance, reflecting a turnaround driven by shedding unprofitable units and investing in efficiency and te...
UnitedHealth Group raised its 2026 earnings outlook following a 52% increase in third-quarter operating profit to $6.6 billion, driven by lower medical costs and better operational efficiency. The company now expects adjusted earnings of at least $20...
UnitedHealth shares rose 4% after beating Q3 2026 earnings estimates with adjusted EPS of $4.69 and raising its full-year outlook to at least $20.50. The earnings beat was driven by improved medical care ratio, helped partly by a $610 million reserve...
UnitedHealth Group reported Q3 earnings that exceeded expectations with EPS 13% above consensus, driven by a successful turnaround strategy focusing on shedding unprofitable patient groups and controlling costs. This led to a net margin increase from...
